Galmed Pharmaceuticals Ltd. — Form D

Galmed Pharmaceuticals Ltd. of TEL AVIV, L3, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-15. The offering totals $350K, of which $100K was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2017-08-15
Form: D
Accession: 0001144204-17-043518
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $350K
Amount sold: $100K
Remaining: $250K
Investors: 1
Date of first sale: 2017-08-09
Security types: equity
Revenue range: $1 - $1,000,000
SEC file number: 021-292864

Issuer

Name: Galmed Pharmaceuticals Ltd.
CIK: 0001595353
Entity type: Corporation
Jurisdiction: ISRAEL
Incorporated: 2013
Address: 16 TIOMKIN STREET, TEL AVIV, L3, 6578317
Phone: 972 3 693 8448

Officers, directors & promoters (12)

Name	Role	Location
Allen Baharaff	Director	Tel Aviv, L3
Carol Brosgart	Director	Los Angeles, CA
Chaim Hurvitz	Director	Wilmington, DE
William Marth	Director	Tel Aviv, L3
Shmuel Nir	Director	Tel Aviv, L3
Ran Oren	Director	Tel Aviv, L3
David Sidransky	Director	Germantown, MD
Tali Yaron-Eldar	Director	Tel Aviv, L3
Allen Baharaff	Executive Officer	Tel Aviv, L3
Tali Gorfine	Executive Officer	Tel Aviv, L3
Liat Hayardeny	Executive Officer	Tel Aviv, L3
Yohai Stenzler	Executive Officer	Tel Aviv, L3

More